Why Patients Switch & How We Make It Simple
Understanding Mounjaro and Wegovy Equivalent Doses for Safe Switching
Switching between Mounjaro (tirzepatide) and Wegovy (semaglutide) requires careful consideration of equivalent doses and different mechanisms of action. Mounjaro works as a dual GIP and GLP-1 receptor agonist, while Wegovy targets GLP-1 receptors specifically, though both prescription-only medicines affect appetite regulation and satiety. The dose conversion isn't straightforward as these medications have different pharmacokinetic profiles – Mounjaro escalates to 15mg maximum while Wegovy reaches 2.4mg maintenance dose.
Your prescriber will assess your current Mounjaro dose, treatment response, and individual factors when determining appropriate Wegovy equivalent doses. Generally, patients on Mounjaro 2.5-5mg may transition to Wegovy 0.5-1mg, though this varies significantly based on individual tolerance and clinical response. EverydayMeds prescribers specialise in GLP-1 medication transitions, ensuring your switch between Mounjaro and Wegovy equivalent doses maintains treatment continuity while potentially reducing costs.
Switch & Save: Wegovy Pricing Compared to Mounjaro Costs
Switching from Mounjaro to Wegovy can deliver substantial monthly savings for weight management treatment. Our Wegovy starter dose (0.25mg) costs £79.99 with new customer discount code FIRST40, while maintenance doses reach £209.99 for the 2.4mg pen. Private Mounjaro prescriptions typically cost £150-250 monthly, making Wegovy a cost-effective alternative for many patients seeking similar therapeutic benefits.
EverydayMeds offers strategic bundles that further enhance savings potential when switching between Mounjaro and Wegovy equivalent doses. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides three months of dose escalation for £299.99, while returning customers benefit from the DOSE25 discount code. These structured pricing options make transitioning from higher-cost Mounjaro prescriptions financially advantageous while maintaining clinical efficacy through proper dose conversion protocols.
Clinical Evidence Supporting Mounjaro and Wegovy Equivalent Efficacy
Both Mounjaro and Wegovy demonstrate significant weight management efficacy in clinical trials, though direct head-to-head comparisons are limited due to different trial designs and patient populations. In clinical trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro trials in obesity show similar efficacy ranges, making equivalent doses a viable switching option for patients experiencing cost pressures or seeking different side effect profiles. When considering Mounjaro and Wegovy equivalent doses, your prescriber will evaluate your individual response pattern and adjust accordingly, as clinical effectiveness can vary between these prescription-only medicines despite similar therapeutic goals.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. This prescription-only medicine works primarily in the brain's appetite control centres, reducing hunger signals and promoting earlier satiety after smaller meals. The medication slows gastric emptying, helping patients feel fuller for longer periods while potentially reducing food cravings and portion sizes. Unlike Mounjaro's dual-agonist approach, Wegovy's focused GLP-1 action provides targeted appetite suppression with a well-established safety profile. When switching from Mounjaro and Wegovy equivalent doses, patients typically maintain similar appetite control benefits though the underlying receptor mechanisms differ. The once-weekly FlexTouch injection delivers consistent medication levels, supporting sustained weight management alongside a reduced-calorie diet and increased physical activity.
Seamless Ordering Process for Mounjaro to Wegovy Transitions
EverydayMeds simplifies switching between Mounjaro and Wegovy equivalent doses through our streamlined three-minute online clinical assessment process. Our prescribers review your current medication history, including Mounjaro dosage and response, to determine appropriate Wegovy starting doses and escalation schedule. Standard prescriber review takes three working days, though express 24-hour review is available for patients requiring faster transitions between treatments. Once approved, all Wegovy prescriptions ship via next-day cold-chain delivery, maintaining medication potency from our GPhC-registered pharmacy (#9012878) directly to your door. The entire process eliminates treatment gaps when switching from Mounjaro, ensuring continuous weight management support throughout your medication transition.
Storage Advantages: Wegovy vs Mounjaro Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, particularly important for patients with active lifestyles or travel commitments. While both medications require refrigeration (2-8°C) before first use, Wegovy pens can remain at room temperature below 30°C for up to six weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy more convenient for holidays, business travel, or households with limited refrigeration space. The FlexTouch pen design provides accurate dosing with clear dosage windows, while the mandatory dose escalation schedule (0.25mg to 2.4mg over 16 weeks) allows gradual tolerance building. When considering Mounjaro and Wegovy equivalent doses, these practical factors often influence patient preference alongside clinical and cost considerations. All Wegovy doses use the same pen device, simplifying the transition process for patients familiar with injectable weight management medications.
Personalised Dose Conversion Strategy for Mounjaro and Wegovy Switching
Individual dose conversion between Mounjaro and Wegovy equivalent doses requires personalised clinical assessment rather than standard conversion charts. Factors influencing appropriate Wegovy starting doses include your current Mounjaro dose, duration of treatment, side effect experience, and weight loss response to date. Patients switching from higher Mounjaro doses may start Wegovy at 0.5mg or 1mg rather than the standard 0.25mg starter dose, though this decision rests entirely with your prescriber. EverydayMeds clinical team considers your complete treatment history when recommending optimal switching strategies between these prescription-only medicines.
The transition timeline typically involves completing your current Mounjaro pen before starting Wegovy, though specific timing depends on individual circumstances and prescriber recommendations. Some patients benefit from a brief washout period, while others transition directly to maintain appetite control consistency. Our prescribers provide detailed switching instructions including when to inject your first Wegovy dose and how to monitor for any adjustment period effects during the medication transition.
Complete Your Switch Today: Wegovy Available with Express Delivery
Ready to switch from Mounjaro and explore Wegovy equivalent doses with potential cost savings? EverydayMeds makes transitioning simple through our comprehensive medication switching service backed by qualified prescribers and competitive pricing. New customers save with discount code FIRST40, while returning patients benefit from DOSE25 applied at checkout. Our complete range of Wegovy doses and bundles ensures seamless treatment continuation whether you're switching from Mounjaro or starting weight management treatment fresh. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover how switching could reduce your monthly treatment costs while maintaining effective appetite control. Start your switch today and experience the convenience of expert prescriber support combined with next-day delivery from our trusted GPhC-registered pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
